Display options
Share it on

Exp Clin Cardiol. 2010;15(2):e20-4.

A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction.

Experimental and clinical cardiology

Mamas A Mamas, Ludwig Neyses, Farzin Fath-Ordoubadi

Affiliations

  1. Department of Cardiology, Manchester University;

PMID: 20631859 PMCID: PMC2898530

Abstract

BACKGROUND: Glucose-insulin-potassium (GIK) therapy has been proposed to provide metabolic support to ischemic myocardium. A meta-analysis that included 1932 patients performed 10 years previously demonstrated that GIK therapy may have an important role in reducing mortality after acute myocardial infarction (AMI). Since then, many larger randomized trials investigating the role of GIK in the setting of AMI have been published; hence, the present study repeats the previous meta-analysis performed by the current authors to include these trials.

METHOD AND RESULTS: A systematic MEDLINE search for all randomized, placebo-controlled studies of GIK therapy in the setting of AMI was conducted and a meta-analysis of the mortality data was performed. A total of 16 randomized trials from 1966 to 2008 were identified, with 28,374 patients included in the current meta-analysis. There was a total of 1367 deaths (9.6%) in the GIK group, with 1351 deaths (9.6%) in the control group. Meta-analysis did not reveal any benefit from GIK treatment (OR 1.0; 95% CI 0.9 to 1.1; P=0.9). Subgroup analysis of patients given high-dose GIK and in patients in whom reperfusion was not obtained did not demonstrate a benefit from GIK therapy.

CONCLUSION: A meta-analysis of 16 randomized trials that spanned 40 years and involved more than 28,000 patients did not reveal any mortality benefit for ST segment elevation AMI using GIK therapy when data from the modern thrombolysis/primary percutaneous coronary intervention era were included.

Keywords: Insulin; Meta-analysis; Myocardial infarction

References

  1. Lancet. 1965 Sep 25;2(7413):607-9 - PubMed
  2. Circulation. 1999 Feb 2;99(4):578-88 - PubMed
  3. Am J Cardiol. 1962 Feb;9:166-81 - PubMed
  4. Lancet. 1968 May 4;1(7549):946-8 - PubMed
  5. Am J Cardiol. 1975 Dec;36(7):929-37 - PubMed
  6. Circ Res. 1991 Feb;68(2):466-81 - PubMed
  7. Lancet. 1968 Dec 28;2(7583):1355-60 - PubMed
  8. Circulation. 1998 Nov 24;98(21):2227-34 - PubMed
  9. JAMA. 2005 Jan 26;293(4):437-46 - PubMed
  10. Circulation. 2005 Jun 14;111(23):3078-86 - PubMed
  11. Br Heart J. 1977 Jul;39(7):748-57 - PubMed
  12. Lancet. 1994 Jan 15;343(8890):155-8 - PubMed
  13. Am Heart J. 2004 Jul;148(1):e3 - PubMed
  14. Am Heart J. 1987 Jul;114(1 Pt 1):54-8 - PubMed
  15. Acta Med Scand. 1971 Sep;190(3):213-8 - PubMed
  16. Diabetes Care. 2006 Apr;29(4):765-70 - PubMed
  17. J Am Coll Cardiol. 2006 Apr 18;47(8):1730-1 - PubMed
  18. Circulation. 1997 Aug 19;96(4):1152-6 - PubMed
  19. Eur Heart J. 2005 May;26(10):956-9 - PubMed
  20. Nature. 1975 Feb 27;253(5494):746-7 - PubMed
  21. JAMA. 2007 Nov 28;298(20):2399-405 - PubMed
  22. Eur Heart J. 2006 Jun;27(11):1289-97 - PubMed
  23. Eur Heart J. 2005 Apr;26(7):650-61 - PubMed
  24. Am J Cardiol. 2005 Dec 1;96(11):1517-20 - PubMed
  25. J Am Coll Cardiol. 2003 Sep 3;42(5):784-91 - PubMed
  26. Am J Med. 2002 Mar;112(4):305-11 - PubMed
  27. Circulation. 2001 May 22;103(20):2441-6 - PubMed
  28. Cardiovasc Drugs Ther. 1999 May;13(3):191-200 - PubMed
  29. Circulation. 1975 Jul;52(1):49-57 - PubMed

Publication Types